Dozens of Clinics Market Risky Cell Therapies to Treat Eye Disorders

Scores of clinics across the United States directly advertise expensive - but unproven - stem cell therapies to patients with serious eye diseases, often with devastating results, a new study warns.
Reuters Health Information

Full Story →